Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Leshno

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 25, 2006
A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver diseaseShira Zelber-Sagi, Ada Kessler, Eli Brazowsky, et al.
World Journal of Gastroenterology|January 18, 2013
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantificationShira Zelber-Sagi, Muriel Webb, Nimer Assy, et al.
World Journal of Gastroenterology|December 17, 2011
Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutationNitsan Maharshak, Philippe Halfon, Varda Deutsch, et al.
The International Journal of Biological Markers|February 22, 2014
Role of CD24 polymorphisms in the susceptibility to inflammatory bowel diseaseVictoria Lisiansky, Sarah Kraus, Inna Naumov, et al.
Journal of Viral Hepatitis|June 28, 2019
Liver steatosis is a major predictor of poor outcomes in chronic hepatitis C patients with sustained virological responseNoam Peleg, Assaf Issachar, Orly Sneh Arbib, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|December 26, 2022
Development and validation of a prediction model for histologic progression in patients with nondysplastic Barrett's esophagusNoam Peleg, Yehuda Ringel, Steven Shamah, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 6, 2006
Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis CSigal Fishman, Yoav Lurie, Hava Peretz, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 22, 2023
Revisiting Age Criterion for Surgery in Asymptomatic Primary HyperparathyroidismGilad Horowitz, Moshe Leshno, Elena Izkhakov, et al.
European Urology|March 27, 2018
Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder CancerMichal Sarfaty, Peter S Hall, Kelvin K W Chan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2006
Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population studyRevital Kariv, Moshe Leshno, Anat Beth-Or, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 25, 2006
A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver diseaseShira Zelber-Sagi, Ada Kessler, Eli Brazowsky, et al.
World Journal of Gastroenterology|January 18, 2013
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantificationShira Zelber-Sagi, Muriel Webb, Nimer Assy, et al.
World Journal of Gastroenterology|December 17, 2011
Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutationNitsan Maharshak, Philippe Halfon, Varda Deutsch, et al.
The International Journal of Biological Markers|February 22, 2014
Role of CD24 polymorphisms in the susceptibility to inflammatory bowel diseaseVictoria Lisiansky, Sarah Kraus, Inna Naumov, et al.
Journal of Viral Hepatitis|June 28, 2019
Liver steatosis is a major predictor of poor outcomes in chronic hepatitis C patients with sustained virological responseNoam Peleg, Assaf Issachar, Orly Sneh Arbib, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|December 26, 2022
Development and validation of a prediction model for histologic progression in patients with nondysplastic Barrett's esophagusNoam Peleg, Yehuda Ringel, Steven Shamah, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 6, 2006
Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis CSigal Fishman, Yoav Lurie, Hava Peretz, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 22, 2023
Revisiting Age Criterion for Surgery in Asymptomatic Primary HyperparathyroidismGilad Horowitz, Moshe Leshno, Elena Izkhakov, et al.
European Urology|March 27, 2018
Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder CancerMichal Sarfaty, Peter S Hall, Kelvin K W Chan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2006
Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population studyRevital Kariv, Moshe Leshno, Anat Beth-Or, et al.
Pageof 12